Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
Simon AG, Lyu SI, Laible M, Wöll S, Türeci Ö, Şahin U, Alakus H, Fahrig L, Zander T, Buettner R, Bruns CJ, Schroeder W, Gebauer F, Quaas A. Simon AG, et al. Among authors: buettner r. J Transl Med. 2023 Aug 17;21(1):552. doi: 10.1186/s12967-023-04433-8. J Transl Med. 2023. PMID: 37592303 Free PMC article.
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
Albin J, Fahrig L, Siemanowski J, Rehkaemper J, Gebauer F, Zander T, Buettner R, Bruns CJ, Schroeder W, Alakus H, Hieggelke L, Quaas A. Albin J, et al. Among authors: buettner r. J Cancer Res Clin Oncol. 2023 Jul;149(8):5289-5300. doi: 10.1007/s00432-022-04460-w. Epub 2022 Nov 23. J Cancer Res Clin Oncol. 2023. PMID: 36416959 Free PMC article.
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
Dos Santos Cunha AC, Simon AG, Zander T, Buettner R, Bruns CJ, Schroeder W, Gebauer F, Quaas A. Dos Santos Cunha AC, et al. Among authors: buettner r. J Cancer Res Clin Oncol. 2023 Aug;149(10):6917-6929. doi: 10.1007/s00432-023-04650-0. Epub 2023 Feb 24. J Cancer Res Clin Oncol. 2023. PMID: 36826594 Free PMC article.
Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome.
Müller P, Velazquez Camacho O, Yazbeck AM, Wölwer C, Zhai W, Schumacher J, Heider D, Buettner R, Quaas A, Hillmer AM. Müller P, et al. Among authors: buettner r. Comput Struct Biotechnol J. 2023 Feb 15;21:1573-1583. doi: 10.1016/j.csbj.2023.02.024. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36874157 Free PMC article.
Tumour area infiltration and cell count in endoscopic biopsies of therapy-naive upper GI tract carcinomas by QuPath analysis: implications for predictive biomarker testing.
Scheel AH, Lamberty H, Tolkach Y, Gebauer F, Schoemig-Markiefka B, Zander T, Buettner R, Rueschoff J, Bruns CJ, Schroeder W, Quaas A. Scheel AH, et al. Among authors: buettner r. Sci Rep. 2023 Oct 16;13(1):17580. doi: 10.1038/s41598-023-43903-3. Sci Rep. 2023. PMID: 37845307 Free PMC article.
437 results